Organization Overview
Historical Acquisition Tree
Alternative names
vemurafenib (zelboraf) (2006)
Adenocarcinoma, Clear Cell (Phase 2)
Adenomyoepithelioma (Phase 2)
Arthritis (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
Genital Neoplasms, Female (Phase 2)
Giant Cell Tumor of Tendon Sheath (Phase 1)
Giant Cell Tumors (Phase 1)
Glioblastoma (Phase 2)
Histiocytosis (Phase 2)
Hodgkin Disease (Phase 2)
Leukemia (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 2)
Nerve Sheath Neoplasms (Phase 2)
Neurofibrosarcoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Preleukemia (Phase 1)
Prostatic Neoplasms (Phase 2)
Sarcoma (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Syndrome (Phase 1)
Synovitis (Phase 1)
Synovitis, Pigmented Villonodular (Phase 1)
Thyroid Neoplasms (Phase 2)